Dartmouth-Hitchcock Medical Center: Neoplasms trials

The registry lists 17 Neoplasms studies with Dartmouth-Hitchcock Medical Center as lead sponsor. 2 are open to participants now and 6 have results posted.

Phase 1 3Phase 2 3Phase 4 1No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Immune Profiling for Cancer Immunotherapy ResponseRecruitingNCT06116032
• CAncer TReatment INformed by the Molecular Tumor Board At DartmouthRecruitingNCT05405413Phase 2
• Screen to Save 2: Rural Cancer Screening Educational InterventionCompletedNCT04414306Not applicableResults posted
• Education About Health and Cancer StudyCompletedNCT04409782Not applicableResults posted
• High-density EEG in Neurological DisordersCompletedNCT04266041Not applicableResults posted
• Cyclophosphamide for Hematopoietic Stem Cell Mobilization in Patients With a Hematologic MalignancyCompletedNCT02139280Phase 2Results posted
• Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic MalignanciesCompletedNCT00741455Not applicableResults posted
• Feasibility and Cost Analysis of PBSC Mobilization Using Pegfilgrastim in Hematologic MalignanciesTerminatedNCT00689884Not applicableResults posted
• Developing and Testing an Online Pathway From Screening to Treatment for Depression in Oncology: iPath*D (Aim 2)Active, not recruitingNCT05302375Not applicable
• CORE: CO Monitoring for Reach and Efficacy in Tobacco Treatment for Cancer PatientsCompletedNCT04675515Not applicable
• Feasibility of a Creative Writing Intervention in an Advanced Cancer Population: A Single Arm, Consecutive Cohort StudyCompletedNCT02575898Not applicable
• Genetically-informed Therapies for Patients With Metastatic CancerWithdrawnNCT02000739Phase 4
• A Dose Escalation Study of Hydroxyurea in Combination With SCH900776 in Advanced Malignant Solid TumorsWithdrawnNCT01521299Phase 1
• Study of Palliative Care Intervention for Advanced Cancer Patients and Their Caregivers -Educate Nurture Advise Before Life Ends (ENABLE III)CompletedNCT01245621Not applicable
• A Molecular Pharmacodynamic Dose-titration Trial of Conjugated Linoleic Acid (CLA; Clarinol®) in Patients With Advanced Solid TumorsTerminatedNCT00951158Phase 1
• Temozolomide Plus PEG-Interferon Alfa-2B in Treating Patients With Advanced Solid TumorsCompletedNCT00014261Phase 1
• Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or LymphomaTerminatedNCT00005812Phase 2